Meteoric economic growth, strengthening R&D, and digital transformation are currently the top strategic priorities for pharmaceuticals industry driven by changing consumer behaviour, cyberthreats, and emerging competitors. This necessitates them to fully utilise advanced technologies especially those dealing with data to rise above the saturated market post-COVID era.